Status:
COMPLETED
Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux
Lead Sponsor:
Groupe Oncologie Radiotherapie Tete et Cou
Conditions:
HNSCC
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The aim of the trial is to study the efficacy of adding concomitant chemotherapy (carboplatin/5FU) to Erbitux-radiotherapy in patients with locally advanced head and neck cancer.
Eligibility Criteria
Inclusion
- Squamous cell carcinoma of oral cavity, oropharynx, hypopharynx, larynx
- Stage III - IV (T0-T4, N0-N2b, M0)
- Not resected
- Karnofsky PS\>=80
- Informed consent signed
Exclusion
- Contra indication to chemotherapy or cetuximab
Key Trial Info
Start Date :
February 15 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2019
Estimated Enrollment :
406 Patients enrolled
Trial Details
Trial ID
NCT00609284
Start Date
February 15 2008
End Date
March 26 2019
Last Update
April 15 2020
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier Annecy
Annecy, France, 74000
2
Centre Jean Perrin
Clermont-Ferrand, France, 63000
3
Centre Guillaume Le Conquerant
Le Havre, France, 76600
4
Centre hospitalier de Bretagne Sud
Lorient, France, 56322